Overview
Anthem has created a group called “Platform Technologies” to perform innovative research that would result in proprietary assays/products. These technologies can either be offered as a service, or out-licensed to biotech, biopharmaceutical, pharmaceutical and industries in the diagnostics, nutraceutical, manufacturing, agricultural and animal healthcare sectors.Since inception in 2008, the group has developed technologies, and is working on a number of platforms based on the need of the day in the various market sectors. This group also collaborates with other internal departments, and clients to understand potential opportunities, and suggest and design assays/products.
The innovations that have come out from this group has resulted in various recognitions and funding from Government agencies including:
- The best innovator award by The Department of Science and Technology - Lockheed Martin India Innovation Growth Programme, 2012; this is for the cell based genotoxicity assay.
- SBIRI (Small Business Innovation Research Initiative) funding by Department of Biotechnology, Govt. of India for developing novel production strains of bacteria.
- BIPP 2011 grant for developing effective Biotransformation strategies to offer ‘green chemistry’ alternatives in manufacturing compounds.
Grants & Journals